Moreover, we demonstrate that OTUB2 is a general regulator of PD-L1 since genetic depletion or pharmaceutical inhibition of OTUB2 expression profoundly impacts PD-L1 protein stability in multiple cancers, especially in tumors generally expressing low levels of PD-L1. The gene discussed is OTUB2; the disease is cancer.